nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—ABCB1—Methylprednisolone—multiple sclerosis	0.0568	0.0995	CbGbCtD
Clobazam—CYP3A4—Fingolimod—multiple sclerosis	0.0528	0.0925	CbGbCtD
Clobazam—CYP2C19—Prednisone—multiple sclerosis	0.0426	0.0747	CbGbCtD
Clobazam—CYP2B6—Dexamethasone—multiple sclerosis	0.0419	0.0734	CbGbCtD
Clobazam—ABCB1—Mitoxantrone—multiple sclerosis	0.0414	0.0726	CbGbCtD
Clobazam—ABCB1—Betamethasone—multiple sclerosis	0.0369	0.0647	CbGbCtD
Clobazam—ABCB1—Prednisolone—multiple sclerosis	0.0364	0.0638	CbGbCtD
Clobazam—ABCB1—Prednisone—multiple sclerosis	0.0344	0.0603	CbGbCtD
Clobazam—CYP3A4—Methylprednisolone—multiple sclerosis	0.034	0.0596	CbGbCtD
Clobazam—CYP2C19—Dexamethasone—multiple sclerosis	0.0266	0.0466	CbGbCtD
Clobazam—CYP3A4—Triamcinolone—multiple sclerosis	0.0258	0.0452	CbGbCtD
Clobazam—CYP3A4—Mitoxantrone—multiple sclerosis	0.0248	0.0435	CbGbCtD
Clobazam—CYP3A4—Betamethasone—multiple sclerosis	0.0221	0.0388	CbGbCtD
Clobazam—CYP3A4—Prednisolone—multiple sclerosis	0.0218	0.0382	CbGbCtD
Clobazam—ABCB1—Dexamethasone—multiple sclerosis	0.0215	0.0376	CbGbCtD
Clobazam—CYP3A4—Prednisone—multiple sclerosis	0.0206	0.0361	CbGbCtD
Clobazam—ABCB1—Methotrexate—multiple sclerosis	0.0173	0.0302	CbGbCtD
Clobazam—CYP3A4—Dexamethasone—multiple sclerosis	0.0129	0.0225	CbGbCtD
Clobazam—SLC6A11—spinal cord—multiple sclerosis	0.00841	0.0809	CbGeAlD
Clobazam—SLC6A11—nervous system—multiple sclerosis	0.00708	0.0682	CbGeAlD
Clobazam—SLC6A11—central nervous system—multiple sclerosis	0.00682	0.0656	CbGeAlD
Clobazam—SLC6A1—brainstem—multiple sclerosis	0.00633	0.0609	CbGeAlD
Clobazam—SLC6A1—retina—multiple sclerosis	0.00611	0.0588	CbGeAlD
Clobazam—SLC6A11—brain—multiple sclerosis	0.00541	0.0521	CbGeAlD
Clobazam—SLC6A1—medulla oblongata—multiple sclerosis	0.00441	0.0425	CbGeAlD
Clobazam—SLC6A1—midbrain—multiple sclerosis	0.00403	0.0388	CbGeAlD
Clobazam—SLC6A1—spinal cord—multiple sclerosis	0.00394	0.0379	CbGeAlD
Clobazam—SLC6A1—nervous system—multiple sclerosis	0.00332	0.0319	CbGeAlD
Clobazam—SLC6A1—central nervous system—multiple sclerosis	0.00319	0.0307	CbGeAlD
Clobazam—SLC6A1—cerebellum—multiple sclerosis	0.00312	0.03	CbGeAlD
Clobazam—SLC6A11—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00268	0.0342	CbGpPWpGaD
Clobazam—SLC6A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00261	0.0334	CbGpPWpGaD
Clobazam—SLC6A1—brain—multiple sclerosis	0.00254	0.0244	CbGeAlD
Clobazam—GABRB2—brainstem—multiple sclerosis	0.00252	0.0242	CbGeAlD
Clobazam—GABRA1—brainstem—multiple sclerosis	0.00223	0.0214	CbGeAlD
Clobazam—SLC6A11—Neuronal System—KCNA3—multiple sclerosis	0.00213	0.0273	CbGpPWpGaD
Clobazam—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.0021	0.0269	CbGpPWpGaD
Clobazam—SLC6A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00182	0.0233	CbGpPWpGaD
Clobazam—GABRG2—medulla oblongata—multiple sclerosis	0.00176	0.0169	CbGeAlD
Clobazam—GABRB2—medulla oblongata—multiple sclerosis	0.00176	0.0169	CbGeAlD
Clobazam—SLC6A1—Neuronal System—KCNA3—multiple sclerosis	0.00172	0.022	CbGpPWpGaD
Clobazam—GABRB2—midbrain—multiple sclerosis	0.00161	0.0155	CbGeAlD
Clobazam—GABRG2—midbrain—multiple sclerosis	0.00161	0.0155	CbGeAlD
Clobazam—GABRB2—spinal cord—multiple sclerosis	0.00157	0.0151	CbGeAlD
Clobazam—GABRG2—spinal cord—multiple sclerosis	0.00157	0.0151	CbGeAlD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00157	0.02	CbGpPWpGaD
Clobazam—GABRA1—medulla oblongata—multiple sclerosis	0.00155	0.0149	CbGeAlD
Clobazam—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00147	0.0188	CbGpPWpGaD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00142	0.0181	CbGpPWpGaD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00142	0.0181	CbGpPWpGaD
Clobazam—GABRA1—midbrain—multiple sclerosis	0.00142	0.0136	CbGeAlD
Clobazam—CYP2C18—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.0014	0.0179	CbGpPWpGaD
Clobazam—CYP2C18—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.0014	0.0179	CbGpPWpGaD
Clobazam—GABRA1—spinal cord—multiple sclerosis	0.00138	0.0133	CbGeAlD
Clobazam—GABRB2—nervous system—multiple sclerosis	0.00132	0.0127	CbGeAlD
Clobazam—GABRG2—nervous system—multiple sclerosis	0.00132	0.0127	CbGeAlD
Clobazam—GABRB2—central nervous system—multiple sclerosis	0.00127	0.0122	CbGeAlD
Clobazam—GABRG2—central nervous system—multiple sclerosis	0.00127	0.0122	CbGeAlD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00126	0.0161	CbGpPWpGaD
Clobazam—GABRB2—cerebellum—multiple sclerosis	0.00124	0.012	CbGeAlD
Clobazam—GABRG2—cerebellum—multiple sclerosis	0.00124	0.012	CbGeAlD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00119	0.0152	CbGpPWpGaD
Clobazam—GABRA1—nervous system—multiple sclerosis	0.00117	0.0112	CbGeAlD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00115	0.0147	CbGpPWpGaD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00115	0.0147	CbGpPWpGaD
Clobazam—GABRA1—central nervous system—multiple sclerosis	0.00112	0.0108	CbGeAlD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0011	0.0141	CbGpPWpGaD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0011	0.0141	CbGpPWpGaD
Clobazam—GABRA1—cerebellum—multiple sclerosis	0.0011	0.0106	CbGeAlD
Clobazam—SLC6A1—Monoamine Transport—IL1B—multiple sclerosis	0.00105	0.0134	CbGpPWpGaD
Clobazam—GABRB2—brain—multiple sclerosis	0.00101	0.00971	CbGeAlD
Clobazam—GABRG2—brain—multiple sclerosis	0.00101	0.00971	CbGeAlD
Clobazam—GABRA1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000978	0.0125	CbGpPWpGaD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000956	0.0122	CbGpPWpGaD
Clobazam—GABRA1—brain—multiple sclerosis	0.000891	0.00857	CbGeAlD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000829	0.0106	CbGpPWpGaD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000811	0.0104	CbGpPWpGaD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000811	0.0104	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000796	0.0102	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000781	0.00999	CbGpPWpGaD
Clobazam—SLC6A1—Monoamine Transport—TNF—multiple sclerosis	0.000759	0.00971	CbGpPWpGaD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000698	0.00892	CbGpPWpGaD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000698	0.00892	CbGpPWpGaD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000689	0.0088	CbGpPWpGaD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000689	0.0088	CbGpPWpGaD
Clobazam—CYP2B6—nervous system—multiple sclerosis	0.000687	0.00661	CbGeAlD
Clobazam—ABCB1—retina—multiple sclerosis	0.000677	0.00651	CbGeAlD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000668	0.00854	CbGpPWpGaD
Clobazam—CYP2B6—central nervous system—multiple sclerosis	0.000662	0.00637	CbGeAlD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000641	0.0082	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00063	0.00805	CbGpPWpGaD
Clobazam—CYP2C18—Biological oxidations—CYP27B1—multiple sclerosis	0.000611	0.00781	CbGpPWpGaD
Clobazam—CYP2C18—Biological oxidations—CYP24A1—multiple sclerosis	0.000611	0.00781	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000603	0.00771	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000603	0.00771	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000603	0.00771	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—BCHE—multiple sclerosis	0.000599	0.00765	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—KCNA3—multiple sclerosis	0.000582	0.00745	CbGpPWpGaD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000566	0.00723	CbGpPWpGaD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000566	0.00723	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—KCNA3—multiple sclerosis	0.000533	0.00681	CbGpPWpGaD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000527	0.00674	CbGpPWpGaD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000527	0.00674	CbGpPWpGaD
Clobazam—CYP2B6—brain—multiple sclerosis	0.000525	0.00506	CbGeAlD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00052	0.00665	CbGpPWpGaD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00052	0.00665	CbGpPWpGaD
Clobazam—CYP3A4—nervous system—multiple sclerosis	0.000519	0.00499	CbGeAlD
Clobazam—CYP3A4—central nervous system—multiple sclerosis	0.0005	0.00481	CbGeAlD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000499	0.00639	CbGpPWpGaD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000499	0.00639	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—SRM—multiple sclerosis	0.000492	0.00629	CbGpPWpGaD
Clobazam—Visual impairment—Prednisolone—multiple sclerosis	0.000491	0.00199	CcSEcCtD
Clobazam—ABCB1—medulla oblongata—multiple sclerosis	0.000489	0.00471	CbGeAlD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000486	0.00621	CbGpPWpGaD
Clobazam—Leukopenia—Mitoxantrone—multiple sclerosis	0.000484	0.00196	CcSEcCtD
Clobazam—Weight increased—Dexamethasone—multiple sclerosis	0.000483	0.00195	CcSEcCtD
Clobazam—Weight increased—Betamethasone—multiple sclerosis	0.000483	0.00195	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—BCHE—multiple sclerosis	0.000483	0.00617	CbGpPWpGaD
Clobazam—Asthenia—Cladribine—multiple sclerosis	0.000481	0.00195	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000477	0.00609	CbGpPWpGaD
Clobazam—Pruritus—Cladribine—multiple sclerosis	0.000475	0.00192	CcSEcCtD
Clobazam—Muscular weakness—Prednisone—multiple sclerosis	0.000472	0.00191	CcSEcCtD
Clobazam—Cough—Mitoxantrone—multiple sclerosis	0.000471	0.00191	CcSEcCtD
Clobazam—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000471	0.00191	CcSEcCtD
Clobazam—GABRA1—Neuronal System—KCNA3—multiple sclerosis	0.000466	0.00595	CbGpPWpGaD
Clobazam—Abdominal distension—Prednisone—multiple sclerosis	0.000465	0.00188	CcSEcCtD
Clobazam—Hallucination—Methylprednisolone—multiple sclerosis	0.000465	0.00188	CcSEcCtD
Clobazam—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000462	0.0059	CbGpPWpGaD
Clobazam—Myalgia—Mitoxantrone—multiple sclerosis	0.00046	0.00186	CcSEcCtD
Clobazam—Diarrhoea—Cladribine—multiple sclerosis	0.000459	0.00186	CcSEcCtD
Clobazam—Anxiety—Mitoxantrone—multiple sclerosis	0.000458	0.00185	CcSEcCtD
Clobazam—Lethargy—Methotrexate—multiple sclerosis	0.000456	0.00185	CcSEcCtD
Clobazam—Visual impairment—Methylprednisolone—multiple sclerosis	0.00045	0.00182	CcSEcCtD
Clobazam—Feeling abnormal—Azathioprine—multiple sclerosis	0.00045	0.00182	CcSEcCtD
Clobazam—Osteoarthritis—Methotrexate—multiple sclerosis	0.000447	0.00181	CcSEcCtD
Clobazam—ABCB1—midbrain—multiple sclerosis	0.000447	0.0043	CbGeAlD
Clobazam—Confusional state—Mitoxantrone—multiple sclerosis	0.000445	0.0018	CcSEcCtD
Clobazam—Dizziness—Cladribine—multiple sclerosis	0.000444	0.00179	CcSEcCtD
Clobazam—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000442	0.00565	CbGpPWpGaD
Clobazam—Infection—Mitoxantrone—multiple sclerosis	0.000438	0.00177	CcSEcCtD
Clobazam—Eye disorder—Methylprednisolone—multiple sclerosis	0.000437	0.00177	CcSEcCtD
Clobazam—ABCB1—spinal cord—multiple sclerosis	0.000436	0.0042	CbGeAlD
Clobazam—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000432	0.00175	CcSEcCtD
Clobazam—Body temperature increased—Azathioprine—multiple sclerosis	0.000431	0.00174	CcSEcCtD
Clobazam—Skin disorder—Mitoxantrone—multiple sclerosis	0.000428	0.00173	CcSEcCtD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000427	0.00546	CbGpPWpGaD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000427	0.00546	CbGpPWpGaD
Clobazam—Irritability—Methotrexate—multiple sclerosis	0.000427	0.00173	CcSEcCtD
Clobazam—Vomiting—Cladribine—multiple sclerosis	0.000427	0.00173	CcSEcCtD
Clobazam—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000426	0.00172	CcSEcCtD
Clobazam—Rash—Cladribine—multiple sclerosis	0.000423	0.00171	CcSEcCtD
Clobazam—Hallucination—Betamethasone—multiple sclerosis	0.000423	0.00171	CcSEcCtD
Clobazam—Hallucination—Dexamethasone—multiple sclerosis	0.000423	0.00171	CcSEcCtD
Clobazam—Dermatitis—Cladribine—multiple sclerosis	0.000423	0.00171	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000421	0.00539	CbGpPWpGaD
Clobazam—Weight increased—Prednisone—multiple sclerosis	0.000421	0.0017	CcSEcCtD
Clobazam—Anorexia—Mitoxantrone—multiple sclerosis	0.00042	0.0017	CcSEcCtD
Clobazam—Ataxia—Methotrexate—multiple sclerosis	0.00042	0.0017	CcSEcCtD
Clobazam—Headache—Cladribine—multiple sclerosis	0.00042	0.0017	CcSEcCtD
Clobazam—Vision blurred—Prednisolone—multiple sclerosis	0.000418	0.00169	CcSEcCtD
Clobazam—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000413	0.00167	CcSEcCtD
Clobazam—Hypotension—Mitoxantrone—multiple sclerosis	0.000412	0.00167	CcSEcCtD
Clobazam—Depression—Prednisone—multiple sclerosis	0.000411	0.00166	CcSEcCtD
Clobazam—Visual impairment—Dexamethasone—multiple sclerosis	0.000409	0.00166	CcSEcCtD
Clobazam—Visual impairment—Betamethasone—multiple sclerosis	0.000409	0.00166	CcSEcCtD
Clobazam—Mental disorder—Methylprednisolone—multiple sclerosis	0.000409	0.00166	CcSEcCtD
Clobazam—Malnutrition—Methylprednisolone—multiple sclerosis	0.000407	0.00165	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000406	0.00519	CbGpPWpGaD
Clobazam—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000403	0.00163	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000402	0.00163	CcSEcCtD
Clobazam—Nausea—Cladribine—multiple sclerosis	0.000398	0.00161	CcSEcCtD
Clobazam—Eye disorder—Dexamethasone—multiple sclerosis	0.000397	0.00161	CcSEcCtD
Clobazam—Eye disorder—Betamethasone—multiple sclerosis	0.000397	0.00161	CcSEcCtD
Clobazam—Somnolence—Mitoxantrone—multiple sclerosis	0.000392	0.00159	CcSEcCtD
Clobazam—Asthma—Methotrexate—multiple sclerosis	0.000386	0.00156	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000384	0.00491	CbGpPWpGaD
Clobazam—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000383	0.00155	CcSEcCtD
Clobazam—Eosinophilia—Methotrexate—multiple sclerosis	0.000383	0.00155	CcSEcCtD
Clobazam—Fatigue—Mitoxantrone—multiple sclerosis	0.00038	0.00154	CcSEcCtD
Clobazam—Constipation—Mitoxantrone—multiple sclerosis	0.000377	0.00153	CcSEcCtD
Clobazam—Diarrhoea—Azathioprine—multiple sclerosis	0.000373	0.00151	CcSEcCtD
Clobazam—Hallucination—Prednisone—multiple sclerosis	0.000368	0.00149	CcSEcCtD
Clobazam—ABCB1—nervous system—multiple sclerosis	0.000367	0.00354	CbGeAlD
Clobazam—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000363	0.00147	CcSEcCtD
Clobazam—Dizziness—Azathioprine—multiple sclerosis	0.000361	0.00146	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00036	0.0046	CbGpPWpGaD
Clobazam—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000359	0.00145	CcSEcCtD
Clobazam—Cough—Triamcinolone—multiple sclerosis	0.000356	0.00144	CcSEcCtD
Clobazam—ABCB1—central nervous system—multiple sclerosis	0.000354	0.0034	CbGeAlD
Clobazam—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000351	0.00449	CbGpPWpGaD
Clobazam—Urticaria—Mitoxantrone—multiple sclerosis	0.00035	0.00142	CcSEcCtD
Clobazam—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00035	0.00142	CcSEcCtD
Clobazam—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000349	0.00141	CcSEcCtD
Clobazam—Myalgia—Triamcinolone—multiple sclerosis	0.000347	0.0014	CcSEcCtD
Clobazam—Vomiting—Azathioprine—multiple sclerosis	0.000347	0.0014	CcSEcCtD
Clobazam—Pneumonia—Methotrexate—multiple sclerosis	0.000346	0.0014	CcSEcCtD
Clobazam—SLC6A11—Metabolism—CYP24A1—multiple sclerosis	0.000346	0.00443	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CYP27B1—multiple sclerosis	0.000346	0.00443	CbGpPWpGaD
Clobazam—Myalgia—Methylprednisolone—multiple sclerosis	0.000346	0.0014	CcSEcCtD
Clobazam—Eye disorder—Prednisone—multiple sclerosis	0.000346	0.0014	CcSEcCtD
Clobazam—ABCB1—cerebellum—multiple sclerosis	0.000346	0.00333	CbGeAlD
Clobazam—Anxiety—Methylprednisolone—multiple sclerosis	0.000345	0.0014	CcSEcCtD
Clobazam—Infestation NOS—Methotrexate—multiple sclerosis	0.000344	0.00139	CcSEcCtD
Clobazam—Infestation—Methotrexate—multiple sclerosis	0.000344	0.00139	CcSEcCtD
Clobazam—Drowsiness—Methotrexate—multiple sclerosis	0.000344	0.00139	CcSEcCtD
Clobazam—Rash—Azathioprine—multiple sclerosis	0.000344	0.00139	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000344	0.00139	CcSEcCtD
Clobazam—Dermatitis—Azathioprine—multiple sclerosis	0.000344	0.00139	CcSEcCtD
Clobazam—Depression—Methotrexate—multiple sclerosis	0.000343	0.00139	CcSEcCtD
Clobazam—Headache—Azathioprine—multiple sclerosis	0.000342	0.00138	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000342	0.00138	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00034	0.00434	CbGpPWpGaD
Clobazam—Dry mouth—Triamcinolone—multiple sclerosis	0.000339	0.00137	CcSEcCtD
Clobazam—Confusional state—Methylprednisolone—multiple sclerosis	0.000335	0.00135	CcSEcCtD
Clobazam—Infection—Triamcinolone—multiple sclerosis	0.000331	0.00134	CcSEcCtD
Clobazam—Sweating—Methotrexate—multiple sclerosis	0.00033	0.00134	CcSEcCtD
Clobazam—Infection—Methylprednisolone—multiple sclerosis	0.00033	0.00133	CcSEcCtD
Clobazam—Insomnia—Prednisolone—multiple sclerosis	0.000327	0.00132	CcSEcCtD
Clobazam—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000326	0.00132	CcSEcCtD
Clobazam—Mental disorder—Prednisone—multiple sclerosis	0.000324	0.00131	CcSEcCtD
Clobazam—Nausea—Azathioprine—multiple sclerosis	0.000324	0.00131	CcSEcCtD
Clobazam—Skin disorder—Methylprednisolone—multiple sclerosis	0.000322	0.0013	CcSEcCtD
Clobazam—Malnutrition—Prednisone—multiple sclerosis	0.000322	0.0013	CcSEcCtD
Clobazam—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000322	0.0013	CcSEcCtD
Clobazam—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000321	0.0013	CcSEcCtD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000319	0.00408	CbGpPWpGaD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000317	0.00405	CbGpPWpGaD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000317	0.00405	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—GPC5—multiple sclerosis	0.000317	0.00405	CbGpPWpGaD
Clobazam—Asthenia—Mitoxantrone—multiple sclerosis	0.000316	0.00128	CcSEcCtD
Clobazam—Myalgia—Betamethasone—multiple sclerosis	0.000315	0.00127	CcSEcCtD
Clobazam—Myalgia—Dexamethasone—multiple sclerosis	0.000315	0.00127	CcSEcCtD
Clobazam—Anxiety—Betamethasone—multiple sclerosis	0.000314	0.00127	CcSEcCtD
Clobazam—Anxiety—Dexamethasone—multiple sclerosis	0.000314	0.00127	CcSEcCtD
Clobazam—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000313	0.004	CbGpPWpGaD
Clobazam—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000313	0.004	CbGpPWpGaD
Clobazam—Hypotension—Methylprednisolone—multiple sclerosis	0.00031	0.00126	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000308	0.00394	CbGpPWpGaD
Clobazam—Vision blurred—Prednisone—multiple sclerosis	0.000304	0.00123	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000303	0.00123	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000302	0.00122	CcSEcCtD
Clobazam—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000302	0.00122	CcSEcCtD
Clobazam—Insomnia—Triamcinolone—multiple sclerosis	0.000301	0.00122	CcSEcCtD
Clobazam—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.0003	0.00384	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.0003	0.00384	CbGpPWpGaD
Clobazam—Insomnia—Methylprednisolone—multiple sclerosis	0.0003	0.00121	CcSEcCtD
Clobazam—Infection—Betamethasone—multiple sclerosis	0.0003	0.00121	CcSEcCtD
Clobazam—Infection—Dexamethasone—multiple sclerosis	0.0003	0.00121	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—TGFB1—multiple sclerosis	0.0003	0.00383	CbGpPWpGaD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000298	0.00382	CbGpPWpGaD
Clobazam—Feeling abnormal—Prednisolone—multiple sclerosis	0.000298	0.00121	CcSEcCtD
Clobazam—Visual impairment—Methotrexate—multiple sclerosis	0.000298	0.00121	CcSEcCtD
Clobazam—Anaemia—Prednisone—multiple sclerosis	0.000298	0.0012	CcSEcCtD
Clobazam—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000296	0.00379	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000296	0.00379	CbGpPWpGaD
Clobazam—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000296	0.0012	CcSEcCtD
Clobazam—Nervous system disorder—Betamethasone—multiple sclerosis	0.000296	0.0012	CcSEcCtD
Clobazam—Agitation—Prednisone—multiple sclerosis	0.000296	0.0012	CcSEcCtD
Clobazam—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000296	0.0012	CcSEcCtD
Clobazam—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000296	0.0012	CcSEcCtD
Clobazam—Erythema multiforme—Methotrexate—multiple sclerosis	0.000292	0.00118	CcSEcCtD
Clobazam—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000292	0.00118	CcSEcCtD
Clobazam—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000292	0.00118	CcSEcCtD
Clobazam—Eye disorder—Methotrexate—multiple sclerosis	0.000289	0.00117	CcSEcCtD
Clobazam—Anorexia—Dexamethasone—multiple sclerosis	0.000288	0.00116	CcSEcCtD
Clobazam—Anorexia—Betamethasone—multiple sclerosis	0.000288	0.00116	CcSEcCtD
Clobazam—Urticaria—Prednisolone—multiple sclerosis	0.000287	0.00116	CcSEcCtD
Clobazam—Fatigue—Triamcinolone—multiple sclerosis	0.000287	0.00116	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000286	0.00366	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000286	0.00366	CbGpPWpGaD
Clobazam—Fatigue—Methylprednisolone—multiple sclerosis	0.000286	0.00116	CcSEcCtD
Clobazam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000284	0.00364	CbGpPWpGaD
Clobazam—Hypotension—Dexamethasone—multiple sclerosis	0.000282	0.00114	CcSEcCtD
Clobazam—Hypotension—Betamethasone—multiple sclerosis	0.000282	0.00114	CcSEcCtD
Clobazam—ABCB1—brain—multiple sclerosis	0.000281	0.0027	CbGeAlD
Clobazam—Vomiting—Mitoxantrone—multiple sclerosis	0.00028	0.00113	CcSEcCtD
Clobazam—Rash—Mitoxantrone—multiple sclerosis	0.000278	0.00112	CcSEcCtD
Clobazam—Dermatitis—Mitoxantrone—multiple sclerosis	0.000278	0.00112	CcSEcCtD
Clobazam—Headache—Mitoxantrone—multiple sclerosis	0.000276	0.00112	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000275	0.00111	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000275	0.00111	CcSEcCtD
Clobazam—Myalgia—Prednisone—multiple sclerosis	0.000274	0.00111	CcSEcCtD
Clobazam—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000274	0.00111	CcSEcCtD
Clobazam—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000274	0.00111	CcSEcCtD
Clobazam—Anxiety—Prednisone—multiple sclerosis	0.000273	0.00111	CcSEcCtD
Clobazam—Insomnia—Dexamethasone—multiple sclerosis	0.000273	0.0011	CcSEcCtD
Clobazam—Insomnia—Betamethasone—multiple sclerosis	0.000273	0.0011	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000272	0.0011	CcSEcCtD
Clobazam—Mental disorder—Methotrexate—multiple sclerosis	0.000271	0.0011	CcSEcCtD
Clobazam—Malnutrition—Methotrexate—multiple sclerosis	0.000269	0.00109	CcSEcCtD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000265	0.00339	CbGpPWpGaD
Clobazam—Urticaria—Triamcinolone—multiple sclerosis	0.000264	0.00107	CcSEcCtD
Clobazam—Urticaria—Methylprednisolone—multiple sclerosis	0.000264	0.00107	CcSEcCtD
Clobazam—Body temperature increased—Triamcinolone—multiple sclerosis	0.000263	0.00106	CcSEcCtD
Clobazam—SLC6A11—Metabolism—RRM1—multiple sclerosis	0.000263	0.00336	CbGpPWpGaD
Clobazam—Decreased appetite—Dexamethasone—multiple sclerosis	0.000262	0.00106	CcSEcCtD
Clobazam—Decreased appetite—Betamethasone—multiple sclerosis	0.000262	0.00106	CcSEcCtD
Clobazam—Nausea—Mitoxantrone—multiple sclerosis	0.000262	0.00106	CcSEcCtD
Clobazam—Infection—Prednisone—multiple sclerosis	0.000261	0.00106	CcSEcCtD
Clobazam—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000261	0.00105	CcSEcCtD
Clobazam—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000261	0.00105	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.00026	0.00333	CbGpPWpGaD
Clobazam—Fatigue—Betamethasone—multiple sclerosis	0.00026	0.00105	CcSEcCtD
Clobazam—Fatigue—Dexamethasone—multiple sclerosis	0.00026	0.00105	CcSEcCtD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000259	0.00331	CbGpPWpGaD
Clobazam—Nervous system disorder—Prednisone—multiple sclerosis	0.000258	0.00104	CcSEcCtD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000257	0.00329	CbGpPWpGaD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000257	0.00329	CbGpPWpGaD
Clobazam—Skin disorder—Prednisone—multiple sclerosis	0.000255	0.00103	CcSEcCtD
Clobazam—Hyperhidrosis—Prednisone—multiple sclerosis	0.000254	0.00103	CcSEcCtD
Clobazam—Vision blurred—Methotrexate—multiple sclerosis	0.000254	0.00103	CcSEcCtD
Clobazam—Anorexia—Prednisone—multiple sclerosis	0.000251	0.00101	CcSEcCtD
Clobazam—Anaemia—Methotrexate—multiple sclerosis	0.000249	0.00101	CcSEcCtD
Clobazam—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000249	0.00101	CcSEcCtD
Clobazam—Feeling abnormal—Betamethasone—multiple sclerosis	0.000249	0.00101	CcSEcCtD
Clobazam—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000247	0.00316	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000246	0.00314	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—TGFB1—multiple sclerosis	0.000241	0.00309	CbGpPWpGaD
Clobazam—Leukopenia—Methotrexate—multiple sclerosis	0.000241	0.000975	CcSEcCtD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000241	0.00308	CbGpPWpGaD
Clobazam—Urticaria—Betamethasone—multiple sclerosis	0.00024	0.00097	CcSEcCtD
Clobazam—Urticaria—Dexamethasone—multiple sclerosis	0.00024	0.00097	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00024	0.000969	CcSEcCtD
Clobazam—Dizziness—Prednisolone—multiple sclerosis	0.000239	0.000968	CcSEcCtD
Clobazam—Asthenia—Triamcinolone—multiple sclerosis	0.000239	0.000966	CcSEcCtD
Clobazam—Body temperature increased—Dexamethasone—multiple sclerosis	0.000239	0.000966	CcSEcCtD
Clobazam—Body temperature increased—Betamethasone—multiple sclerosis	0.000239	0.000966	CcSEcCtD
Clobazam—Asthenia—Methylprednisolone—multiple sclerosis	0.000238	0.000964	CcSEcCtD
Clobazam—Insomnia—Prednisone—multiple sclerosis	0.000238	0.000962	CcSEcCtD
Clobazam—Pruritus—Triamcinolone—multiple sclerosis	0.000235	0.000952	CcSEcCtD
Clobazam—Cough—Methotrexate—multiple sclerosis	0.000235	0.00095	CcSEcCtD
Clobazam—Pruritus—Methylprednisolone—multiple sclerosis	0.000235	0.00095	CcSEcCtD
Clobazam—Myalgia—Methotrexate—multiple sclerosis	0.000229	0.000927	CcSEcCtD
Clobazam—Decreased appetite—Prednisone—multiple sclerosis	0.000229	0.000925	CcSEcCtD
Clobazam—SLC6A11—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000228	0.00292	CbGpPWpGaD
Clobazam—Rash—Prednisolone—multiple sclerosis	0.000228	0.000923	CcSEcCtD
Clobazam—Dermatitis—Prednisolone—multiple sclerosis	0.000228	0.000922	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000228	0.000921	CcSEcCtD
Clobazam—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000227	0.000919	CcSEcCtD
Clobazam—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000227	0.0029	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000227	0.0029	CbGpPWpGaD
Clobazam—Fatigue—Prednisone—multiple sclerosis	0.000227	0.000917	CcSEcCtD
Clobazam—Headache—Prednisolone—multiple sclerosis	0.000227	0.000917	CcSEcCtD
Clobazam—Constipation—Prednisone—multiple sclerosis	0.000225	0.00091	CcSEcCtD
Clobazam—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000224	0.00286	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000224	0.00286	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000223	0.00285	CbGpPWpGaD
Clobazam—Confusional state—Methotrexate—multiple sclerosis	0.000222	0.000896	CcSEcCtD
Clobazam—Dizziness—Triamcinolone—multiple sclerosis	0.00022	0.00089	CcSEcCtD
Clobazam—Dizziness—Methylprednisolone—multiple sclerosis	0.00022	0.000888	CcSEcCtD
Clobazam—Infection—Methotrexate—multiple sclerosis	0.000218	0.000883	CcSEcCtD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000217	0.00278	CbGpPWpGaD
Clobazam—Feeling abnormal—Prednisone—multiple sclerosis	0.000217	0.000877	CcSEcCtD
Clobazam—Asthenia—Betamethasone—multiple sclerosis	0.000217	0.000876	CcSEcCtD
Clobazam—Asthenia—Dexamethasone—multiple sclerosis	0.000217	0.000876	CcSEcCtD
Clobazam—Nervous system disorder—Methotrexate—multiple sclerosis	0.000215	0.000872	CcSEcCtD
Clobazam—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000215	0.00087	CcSEcCtD
Clobazam—Nausea—Prednisolone—multiple sclerosis	0.000215	0.000869	CcSEcCtD
Clobazam—Pruritus—Dexamethasone—multiple sclerosis	0.000214	0.000864	CcSEcCtD
Clobazam—Pruritus—Betamethasone—multiple sclerosis	0.000214	0.000864	CcSEcCtD
Clobazam—Skin disorder—Methotrexate—multiple sclerosis	0.000213	0.000863	CcSEcCtD
Clobazam—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000213	0.00273	CbGpPWpGaD
Clobazam—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000212	0.000859	CcSEcCtD
Clobazam—Vomiting—Triamcinolone—multiple sclerosis	0.000212	0.000856	CcSEcCtD
Clobazam—Vomiting—Methylprednisolone—multiple sclerosis	0.000211	0.000854	CcSEcCtD
Clobazam—Rash—Triamcinolone—multiple sclerosis	0.00021	0.000849	CcSEcCtD
Clobazam—Dermatitis—Triamcinolone—multiple sclerosis	0.00021	0.000848	CcSEcCtD
Clobazam—Anorexia—Methotrexate—multiple sclerosis	0.000209	0.000847	CcSEcCtD
Clobazam—Rash—Methylprednisolone—multiple sclerosis	0.000209	0.000847	CcSEcCtD
Clobazam—Dermatitis—Methylprednisolone—multiple sclerosis	0.000209	0.000846	CcSEcCtD
Clobazam—Urticaria—Prednisone—multiple sclerosis	0.000209	0.000845	CcSEcCtD
Clobazam—Headache—Triamcinolone—multiple sclerosis	0.000208	0.000843	CcSEcCtD
Clobazam—Headache—Methylprednisolone—multiple sclerosis	0.000208	0.000841	CcSEcCtD
Clobazam—Body temperature increased—Prednisone—multiple sclerosis	0.000208	0.000841	CcSEcCtD
Clobazam—Diarrhoea—Dexamethasone—multiple sclerosis	0.000207	0.000836	CcSEcCtD
Clobazam—Diarrhoea—Betamethasone—multiple sclerosis	0.000207	0.000836	CcSEcCtD
Clobazam—Hypotension—Methotrexate—multiple sclerosis	0.000205	0.000831	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.0002	0.00081	CcSEcCtD
Clobazam—Dizziness—Betamethasone—multiple sclerosis	0.0002	0.000808	CcSEcCtD
Clobazam—Dizziness—Dexamethasone—multiple sclerosis	0.0002	0.000808	CcSEcCtD
Clobazam—Insomnia—Methotrexate—multiple sclerosis	0.000199	0.000804	CcSEcCtD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000199	0.00254	CbGpPWpGaD
Clobazam—Nausea—Triamcinolone—multiple sclerosis	0.000198	0.0008	CcSEcCtD
Clobazam—Nausea—Methylprednisolone—multiple sclerosis	0.000197	0.000798	CcSEcCtD
Clobazam—Somnolence—Methotrexate—multiple sclerosis	0.000195	0.00079	CcSEcCtD
Clobazam—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000195	0.00249	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000193	0.00247	CbGpPWpGaD
Clobazam—Vomiting—Dexamethasone—multiple sclerosis	0.000192	0.000777	CcSEcCtD
Clobazam—Vomiting—Betamethasone—multiple sclerosis	0.000192	0.000777	CcSEcCtD
Clobazam—Decreased appetite—Methotrexate—multiple sclerosis	0.000191	0.000773	CcSEcCtD
Clobazam—Rash—Dexamethasone—multiple sclerosis	0.00019	0.00077	CcSEcCtD
Clobazam—Rash—Betamethasone—multiple sclerosis	0.00019	0.00077	CcSEcCtD
Clobazam—Dermatitis—Dexamethasone—multiple sclerosis	0.00019	0.000769	CcSEcCtD
Clobazam—Dermatitis—Betamethasone—multiple sclerosis	0.00019	0.000769	CcSEcCtD
Clobazam—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00019	0.000767	CcSEcCtD
Clobazam—Fatigue—Methotrexate—multiple sclerosis	0.000189	0.000766	CcSEcCtD
Clobazam—Headache—Dexamethasone—multiple sclerosis	0.000189	0.000765	CcSEcCtD
Clobazam—Headache—Betamethasone—multiple sclerosis	0.000189	0.000765	CcSEcCtD
Clobazam—Asthenia—Prednisone—multiple sclerosis	0.000189	0.000763	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000188	0.0024	CbGpPWpGaD
Clobazam—Pruritus—Prednisone—multiple sclerosis	0.000186	0.000753	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000184	0.00235	CbGpPWpGaD
Clobazam—Feeling abnormal—Methotrexate—multiple sclerosis	0.000181	0.000733	CcSEcCtD
Clobazam—Diarrhoea—Prednisone—multiple sclerosis	0.00018	0.000728	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.00018	0.0023	CbGpPWpGaD
Clobazam—Nausea—Betamethasone—multiple sclerosis	0.000179	0.000725	CcSEcCtD
Clobazam—Nausea—Dexamethasone—multiple sclerosis	0.000179	0.000725	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000178	0.00228	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—MAPK1—multiple sclerosis	0.000175	0.00224	CbGpPWpGaD
Clobazam—Urticaria—Methotrexate—multiple sclerosis	0.000175	0.000706	CcSEcCtD
Clobazam—Dizziness—Prednisone—multiple sclerosis	0.000174	0.000703	CcSEcCtD
Clobazam—Body temperature increased—Methotrexate—multiple sclerosis	0.000174	0.000703	CcSEcCtD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000174	0.00222	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000171	0.00219	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00017	0.00218	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000169	0.00216	CbGpPWpGaD
Clobazam—Vomiting—Prednisone—multiple sclerosis	0.000167	0.000676	CcSEcCtD
Clobazam—Rash—Prednisone—multiple sclerosis	0.000166	0.000671	CcSEcCtD
Clobazam—Dermatitis—Prednisone—multiple sclerosis	0.000166	0.00067	CcSEcCtD
Clobazam—Headache—Prednisone—multiple sclerosis	0.000165	0.000666	CcSEcCtD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000164	0.0021	CbGpPWpGaD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000163	0.00209	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—BCHE—multiple sclerosis	0.000163	0.00209	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000159	0.00204	CbGpPWpGaD
Clobazam—Asthenia—Methotrexate—multiple sclerosis	0.000158	0.000638	CcSEcCtD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000157	0.00201	CbGpPWpGaD
Clobazam—Nausea—Prednisone—multiple sclerosis	0.000156	0.000632	CcSEcCtD
Clobazam—Pruritus—Methotrexate—multiple sclerosis	0.000155	0.000629	CcSEcCtD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000154	0.00197	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000152	0.00194	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000152	0.00194	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—BCHE—multiple sclerosis	0.000151	0.00193	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00015	0.00192	CbGpPWpGaD
Clobazam—Diarrhoea—Methotrexate—multiple sclerosis	0.00015	0.000608	CcSEcCtD
Clobazam—GABRG2—Neuronal System—BCHE—multiple sclerosis	0.000149	0.00191	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000149	0.0019	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SRM—multiple sclerosis	0.000148	0.0019	CbGpPWpGaD
Clobazam—Dizziness—Methotrexate—multiple sclerosis	0.000145	0.000588	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—MAPK1—multiple sclerosis	0.000141	0.0018	CbGpPWpGaD
Clobazam—Vomiting—Methotrexate—multiple sclerosis	0.00014	0.000565	CcSEcCtD
Clobazam—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000139	0.00178	CbGpPWpGaD
Clobazam—Rash—Methotrexate—multiple sclerosis	0.000139	0.00056	CcSEcCtD
Clobazam—Dermatitis—Methotrexate—multiple sclerosis	0.000138	0.00056	CcSEcCtD
Clobazam—Headache—Methotrexate—multiple sclerosis	0.000138	0.000557	CcSEcCtD
Clobazam—CYP2C18—Biological oxidations—POMC—multiple sclerosis	0.000137	0.00176	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000137	0.00175	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000137	0.00175	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000135	0.00172	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000135	0.00172	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000134	0.00171	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000132	0.00168	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000131	0.00168	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000131	0.00168	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—BCHE—multiple sclerosis	0.000131	0.00167	CbGpPWpGaD
Clobazam—Nausea—Methotrexate—multiple sclerosis	0.000131	0.000528	CcSEcCtD
Clobazam—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00013	0.00166	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000128	0.00163	CbGpPWpGaD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000127	0.00163	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000125	0.0016	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000122	0.00156	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000119	0.00152	CbGpPWpGaD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000119	0.00152	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000118	0.00151	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000117	0.0015	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000116	0.00148	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000115	0.00147	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000106	0.00135	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000105	0.00134	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYP27B1—multiple sclerosis	0.000105	0.00134	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYP24A1—multiple sclerosis	0.000105	0.00134	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000104	0.00133	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CD80—multiple sclerosis	9.78e-05	0.00125	CbGpPWpGaD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.61e-05	0.00123	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GPC5—multiple sclerosis	9.56e-05	0.00122	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.19e-05	0.00117	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—APOE—multiple sclerosis	9.07e-05	0.00116	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.72e-05	0.00111	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.72e-05	0.00111	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.7e-05	0.00111	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.46e-05	0.00108	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	8.29e-05	0.00106	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	7.97e-05	0.00102	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—RRM1—multiple sclerosis	7.92e-05	0.00101	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.87e-05	0.00101	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—POMC—multiple sclerosis	7.79e-05	0.000996	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	7.73e-05	0.000988	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.58e-05	0.000969	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SRM—multiple sclerosis	7.29e-05	0.000932	CbGpPWpGaD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.13e-05	0.000912	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—ALB—multiple sclerosis	7.1e-05	0.000908	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	6.89e-05	0.000881	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.87e-05	0.000878	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.79e-05	0.000869	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.76e-05	0.000864	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.63e-05	0.000847	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.6e-05	0.000843	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	6.23e-05	0.000797	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.81e-05	0.000743	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.79e-05	0.00074	CbGpPWpGaD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.78e-05	0.000739	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.7e-05	0.000729	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SRM—multiple sclerosis	5.51e-05	0.000705	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SRM—multiple sclerosis	5.38e-05	0.000688	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.36e-05	0.000685	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.21e-05	0.000667	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.14e-05	0.000657	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.14e-05	0.000657	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.11e-05	0.000653	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5e-05	0.000639	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.98e-05	0.000637	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—MAPK1—multiple sclerosis	4.77e-05	0.00061	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.7e-05	0.000601	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.67e-05	0.000597	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.61e-05	0.000589	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—BCHE—multiple sclerosis	4.55e-05	0.000582	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—MAPK1—multiple sclerosis	4.37e-05	0.000558	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.14e-05	0.000529	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.89e-05	0.000498	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.88e-05	0.000496	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.88e-05	0.000496	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—MAPK1—multiple sclerosis	3.82e-05	0.000488	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.79e-05	0.000485	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.79e-05	0.000485	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.79e-05	0.000485	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.79e-05	0.000484	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.55e-05	0.000454	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GPC5—multiple sclerosis	3.47e-05	0.000443	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SRM—multiple sclerosis	3.31e-05	0.000424	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.31e-05	0.000423	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.07e-05	0.000393	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.94e-05	0.000376	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—RRM1—multiple sclerosis	2.87e-05	0.000367	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—APOE—multiple sclerosis	2.74e-05	0.00035	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.65e-05	0.000339	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.64e-05	0.000338	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.59e-05	0.000331	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.47e-05	0.000316	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—POMC—multiple sclerosis	2.35e-05	0.000301	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.33e-05	0.000299	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.33e-05	0.000299	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.28e-05	0.000292	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.24e-05	0.000286	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—ALB—multiple sclerosis	2.14e-05	0.000274	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.14e-05	0.000273	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.96e-05	0.000251	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.79e-05	0.000229	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.77e-05	0.000226	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.69e-05	0.000216	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.66e-05	0.000212	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—BCHE—multiple sclerosis	1.65e-05	0.000211	CbGpPWpGaD
Clobazam—Ketazolam—ALB—multiple sclerosis	1.45e-05	0.235	CrCbGaD
Clobazam—Oxcarbazepine—ALB—multiple sclerosis	1.41e-05	0.228	CrCbGaD
Clobazam—Chlorpromazine—BCHE—multiple sclerosis	1.35e-05	0.219	CrCbGaD
Clobazam—CYP2B6—Metabolism—APOE—multiple sclerosis	1.35e-05	0.000172	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—POMC—multiple sclerosis	1.16e-05	0.000148	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—ALB—multiple sclerosis	1.05e-05	0.000135	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—APOE—multiple sclerosis	1.02e-05	0.00013	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.02e-05	0.00013	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—APOE—multiple sclerosis	9.92e-06	0.000127	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—POMC—multiple sclerosis	8.73e-06	0.000112	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—POMC—multiple sclerosis	8.52e-06	0.000109	CbGpPWpGaD
Clobazam—Clomipramine—ALB—multiple sclerosis	8.1e-06	0.131	CrCbGaD
Clobazam—CYP2C19—Metabolism—ALB—multiple sclerosis	7.96e-06	0.000102	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—ALB—multiple sclerosis	7.77e-06	9.94e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—APOE—multiple sclerosis	6.11e-06	7.82e-05	CbGpPWpGaD
Clobazam—Diazepam—ALB—multiple sclerosis	5.98e-06	0.0968	CrCbGaD
Clobazam—Chlorpromazine—ALB—multiple sclerosis	5.55e-06	0.0899	CrCbGaD
Clobazam—CYP3A4—Metabolism—POMC—multiple sclerosis	5.25e-06	6.71e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—ALB—multiple sclerosis	4.79e-06	6.12e-05	CbGpPWpGaD
